Madison Park Capital Advisors’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,000
Closed -$29.4K 66
2026
Q1
$29.4K Hold
10,000
0.02% 62
2025
Q4
$49.7K Hold
10,000
0.04% 61
2025
Q3
$31.5K Hold
10,000
0.03% 62
2025
Q2
$22.6K Hold
10,000
0.02% 61
2025
Q1
$26.7K Hold
10,000
0.02% 58
2024
Q4
$35.2K Hold
10,000
0.03% 59
2024
Q3
$47.4K Hold
10,000
0.04% 73
2024
Q2
$47K Hold
10,000
0.04% 70
2024
Q1
$45.5K Hold
10,000
0.04% 69
2023
Q4
$41.2K Buy
+10,000
New +$43.6K 0.04% 61

Other funds holding ACHV

Madison Park Capital Advisors's ACHV Position: Q2 2026 in Review

Madison Park Capital Advisors sold out of Achieve Life Sciences (ACHV) in Q2 2026, closing a stake of 10,000 shares — an estimated $29.4K sold.

Madison Park Capital Advisors first reported a position in ACHV in Q4 2023 and held it in 10 quarters. The position peaked at $49.7K in Q4 2025. 11 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Madison Park Capital Advisors reported no remaining Achieve Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Madison Park Capital Advisors sold 10,000 Achieve Life Sciences shares in Q2 2026, an estimated $29.4K.
  • Madison Park Capital Advisors first reported a position in Achieve Life Sciences in Q4 2023 and held it in 10 quarters.
  • Madison Park Capital Advisors's Achieve Life Sciences position peaked at $49.7K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Madison Park Capital Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.